A Dangerous Pattern: High Rates of Drug Combining to be Revealed by Quest Diagnostics at 2018 AAFP Conference

Insights

The American Academy of Family Physicians (AAFP) conference is an annual event that explores family medicine from all angles. This year’s meeting – October 9-13 in New Orleans – will gather over 4,000 physicians from across the country to share best practices and learn from each other. Among the topics to be a major area of […]

Quest Diagnostics Collaborates with Leading Physicians in Hereditary Cancer Study

Insights

Quest Diagnostics, Inc. is the exclusive genetic-testing partner for the BRCA Founder Outreach Study (BFOR), which offers BRCA testing to 4,000 Ashkenazi-Jewish men and women in four major metropolitan U.S. cities: New York, Los Angeles, Philadelphia, and Boston.  One of the BFOR Study’s main goals is to explore new ways our healthcare system can use genetic testing […]

Cytogenetic Analysis in Chronic Lymphocytic Leukemia (CLL): The Rediscovered Value of Metaphase Chromosome Analysis

Insights

B-cell chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western world, and has a highly variable clinical course, ranging from indolent to highly aggressive.

If I had only known:  Congenital CMV infection prevention, diagnosis, and treatment

Insights

Newborn cytomegalovirus (CMV) testing is not routinely performed, and most pregnant women are not aware of congenital CMV infection prevention or potential risk in pregnancy.

Case Report of a Rare Fetal Chimera

Insights

Congenital chimeras are rare and often come to attention due to ambiguous genitalia or a discrepancy in the sex chromosome

Cervical Cancer Prevention: Liquid-Based Cytology and hr-HPV Co-testing Remain the Most Effective Cervical Cancer Screening Method

Insights

In our opinion, the best evidence still supports screening with Pap and hr-HPV together to provide the best protection against cervical cancer for women ages 30 to 65.

Are Longer-term Antibiotics More Effective than Shorter-term Treatment for Lyme disease?

Insights

For some patients infected with Borrelia burgdorferi, symptoms may persist for months or even longer, leading to the question of whether such patients have “chronic Lyme disease,”

22q11.2 Deletion Syndrome: Awareness Can Make a Difference

Insights

Prenatal screening for the 22q11.2 deletion is now available by cell-free DNA screening, also known as noninvasive prenatal screening.